Genotoxic evaluation of selective serotonin-reuptake inhibitors by use of the somatic mutation and recombination test in Drosophila melanogaster

Tables for determining the statistical significance of mutation frequencies

Marvin A. Kastenbaum, K.O. Bowman · Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis · 1970 · 973 citations

Life Sciences, Biostatistics, Genetics +11

Birth Outcomes in Pregnant Women Taking Fluoxetine

Christina Chambers, Kathleen A. Johnson, Lyn M. Dick et al. · New England Journal of Medicine · 1996 · 738 citations · Full text

Public Health, Maternal Health, Obstetrics +14

Somatic mutation and recombination test in <i>Drosophila melanogaster</i>

Ulrich Gräf, F.E. Würgler, Alan J. Katz et al. · Environmental Mutagenesis · 1984 · 674 citations

Life Sciences, Entomology, Toxicology +17

The effect of selective serotonin re‐uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes.

H.K. Crewe, MS Lennard, GT Tucker et al. · British Journal of Clinical Pharmacology · 1992 · 471 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Sertraline, 1S,4S-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthylamine, a new uptake inhibitor with selectivity for serotonin.

B. Kenneth Koe, Arthur D. Weissman, W. M. WELCH et al. · Journal of Pharmacology and Experimental Therapeutics · 1983 · 258 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +9